Utility of vaginal vault cytology in the local recurrence of cervical cancer

BMC Women's Health

Table 3 Univariate and multivariate analyses for survival outcomes after recurrence in patients with local recurrence

	Univariate		Multivariate
	Hazard ratio [95% CI]	p-value^*	Hazard ratio [95% CI]	p-value^*
Diagnosis method at recurrence
Pap Smear	ref		Included but not significant in final multivariate analysis
Symptom	19.10 [1.99–183.40]	0.011
Tumor Marker	12.03 [0.91–159.10]	0.059
Imaging analysis	5.69 [1.09–29.77]	0.039
Initial treatment
Ope, ope + chemo	ref		Included but not significant in final multivariate analysis
Ope + RT or CCRT, RT, CCRT	5.84 [1.16–29.38]	0.030
Salvage therapy after recurrence
RT	ref		ref
Chemotherapy	18.52 [2.15–160]	0.008	18.52 [2.15–160]	0.008

^*Cox regression analysis was used
Ope Operation, RT Radiation therapy, CCRT Concurrent chemoradiation therapy, Chemo Chemotherapy, LN Lymph node

ISSN: 1472-6874